ArticleFrontiers in oncology2023

Tumor-infiltrating lymphocytes provides recent survival information for early-stage HER2-low-positive breast cancer: a large cohort retrospective study.

Teng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.